Unknown

Dataset Information

0

OGA inhibition by GlcNAc-selenazoline.


ABSTRACT: The title compound, which differs from the powerful O-GlcNAcase (OGA) inhibitor GlcNAc-thiazoline only at the chalcogen atom (Se for S), is a much weaker inhibitor in a direct OGA assay. In human cells, however, the selenazoline shows comparable ability to induce hyper-O-GlcNAc-ylation, and the two show similar reduction of insulin-stimulated translocation of glucose transporter 4 in differentiated 3T3 adipocytes.

SUBMITTER: Kim EJ 

PROVIDER: S-EPMC4210863 | biostudies-literature | 2010 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications


The title compound, which differs from the powerful O-GlcNAcase (OGA) inhibitor GlcNAc-thiazoline only at the chalcogen atom (Se for S), is a much weaker inhibitor in a direct OGA assay. In human cells, however, the selenazoline shows comparable ability to induce hyper-O-GlcNAc-ylation, and the two show similar reduction of insulin-stimulated translocation of glucose transporter 4 in differentiated 3T3 adipocytes. ...[more]

Similar Datasets

| S-EPMC7856287 | biostudies-literature
| S-EPMC8351506 | biostudies-literature
| S-EPMC1567679 | biostudies-literature
| S-EPMC4583686 | biostudies-literature
| S-EPMC8898497 | biostudies-literature
| S-EPMC6450885 | biostudies-literature
| S-EPMC2854817 | biostudies-literature
| S-EPMC6823131 | biostudies-literature
| S-EPMC4914298 | biostudies-literature
| S-EPMC9387508 | biostudies-literature